GSK press releases Follow Nucala (mepolizumab) approved in China for use in adults with chronic obstructive pulmonary disease (COPD) Nucala is the first and only monthly biologic approved in China studied in a wide COPD population https://www.gsk.com/en-gb/media/press-releases/nucala-mepolizumab-approved-in-china/ gsk.com
